Skip to main content
Top
Published in: World Journal of Surgery 7/2010

01-07-2010

Predictors of Mortality in Skin and Soft-tissue Infections Caused by Vibrio vulnificus

Authors: Tsai-Nung Kuo Chou, Wai-Nang Chao, Cheng Yang, Ruey-Hong Wong, Kwo-Chang Ueng, Shiuan-Chih Chen

Published in: World Journal of Surgery | Issue 7/2010

Login to get access

Abstract

Background

Vibrio vulnificus infection can progress rapidly in skin or soft tissue, and it is potentially life-threatening. The purpose of the present study was to explore the predictors of mortality in patients with V. vulnificus infections of skin or soft tissue.

Methods

The medical records of 119 consecutive patients aged ≥18 years, hospitalized for V. vulnificus infections of skin or soft tissue between January 2000 and December 2007 were reviewed. Co-morbidities, clinical manifestations, laboratory studies, treatments, and outcomes were analyzed. Multiple logistic regression with the exact method was performed.

Results

The mean age of the patients was 63.7 ± 12.0 years. Twenty-four patients died, yielding an overall case fatality rate of 20%. Of the 24 deaths, 20 (83%) occurred within 72 h after hospital admission. Of 119 patients, 45 patients had primary septicemia, and 74 patients had wound infection. Multivariate analysis revealed that the following factors were associated with mortality: hemorrhagic bullous skin lesions/necrotizing fasciitis (p = 0.003), primary septicemia (p = 0.042), a greater organ dysfunction and/or infection score (p = 0.005), absence of leukocytosis (p = 0.0001), and hypoalbuminemia (p = 0.003). Treatment with surgical intervention plus antibiotics (p = 0.038) and surgical intervention within 24 h after admission (p = 0.017) were protective factors.

Conclusions

This study demonstrates that the presence of hemorrhagic bullous skin lesions/necrotizing fasciitis, primary septicemia, a greater severity-of-illness, absence of leukocytosis, and hypoalbuminemia were the significant risk factors for mortality in these patients. Moreover, patients treated with surgery plus antibiotics, especially those receiving a prompt surgical evaluation within 24 h after hospital admission, may have a better prognosis.
Literature
1.
go back to reference Hollis DG, Weaver RE, Baker CN et al (1976) Halophilic Vibrio species isolated from blood cultures. J Clin Microbiol 3:425–431PubMed Hollis DG, Weaver RE, Baker CN et al (1976) Halophilic Vibrio species isolated from blood cultures. J Clin Microbiol 3:425–431PubMed
2.
go back to reference Klontz KC, Lieb S, Schreiber M et al (1988) Syndromes of Vibrio vulnificus infections. Clinical and epidemiologic features in Florida cases, 1981–1987. Ann Intern Med 109:318–323PubMed Klontz KC, Lieb S, Schreiber M et al (1988) Syndromes of Vibrio vulnificus infections. Clinical and epidemiologic features in Florida cases, 1981–1987. Ann Intern Med 109:318–323PubMed
3.
go back to reference Chuang YC, Yuan CY, Liu CY et al (1992) Vibrio vulnificus infection in Taiwan: report of 28 cases and review of clinical manifestations and treatment. Clin Infect Dis 15:271–276PubMed Chuang YC, Yuan CY, Liu CY et al (1992) Vibrio vulnificus infection in Taiwan: report of 28 cases and review of clinical manifestations and treatment. Clin Infect Dis 15:271–276PubMed
4.
go back to reference Howard RJ, Bennett NT (1993) Infections caused by halophilic marine Vibrio bacteria. Ann Surg 217:525–530CrossRefPubMed Howard RJ, Bennett NT (1993) Infections caused by halophilic marine Vibrio bacteria. Ann Surg 217:525–530CrossRefPubMed
5.
go back to reference Hlady WG, Klontz KC (1996) The epidemiology of Vibrio infections in Florida, 1981–1993. J Infect Dis 173:1176–1183PubMed Hlady WG, Klontz KC (1996) The epidemiology of Vibrio infections in Florida, 1981–1993. J Infect Dis 173:1176–1183PubMed
6.
go back to reference Hsueh PR, Lin CY, Tang HJ et al (2004) Vibrio vulnificus in Taiwan. Emerg Infect Dis 10:1363–1368PubMed Hsueh PR, Lin CY, Tang HJ et al (2004) Vibrio vulnificus in Taiwan. Emerg Infect Dis 10:1363–1368PubMed
7.
go back to reference Liu JW, Lee IK, Tang HJ et al (2006) Prognostic factors and antibiotics in Vibrio vulnificus septicemia. Arch Intern Med 166:2117–2123CrossRefPubMed Liu JW, Lee IK, Tang HJ et al (2006) Prognostic factors and antibiotics in Vibrio vulnificus septicemia. Arch Intern Med 166:2117–2123CrossRefPubMed
8.
go back to reference Chung PH, Chuang SK, Tsang T et al (2006) Cutaneous injury and Vibrio vulnificus infection. Emerg Infect Dis 12:1302–1303PubMed Chung PH, Chuang SK, Tsang T et al (2006) Cutaneous injury and Vibrio vulnificus infection. Emerg Infect Dis 12:1302–1303PubMed
9.
go back to reference Inoue Y, Ono T, Matsui T et al (2008) Epidemiological survey of Vibrio vulnificus infection in Japan between 1999 and 2003. J Dermatol 35:129–139CrossRefPubMed Inoue Y, Ono T, Matsui T et al (2008) Epidemiological survey of Vibrio vulnificus infection in Japan between 1999 and 2003. J Dermatol 35:129–139CrossRefPubMed
10.
go back to reference Blake PA, Merson MH, Weaver RE et al (1979) Disease caused by a marine Vibrio. Clinical characteristics and epidemiology. N Engl J Med 300:1–5PubMedCrossRef Blake PA, Merson MH, Weaver RE et al (1979) Disease caused by a marine Vibrio. Clinical characteristics and epidemiology. N Engl J Med 300:1–5PubMedCrossRef
11.
go back to reference Johnston JM, Becker SF, McFarland LM (1985) Vibrio vulnificus. Man and the sea. JAMA 253:2850–2853CrossRefPubMed Johnston JM, Becker SF, McFarland LM (1985) Vibrio vulnificus. Man and the sea. JAMA 253:2850–2853CrossRefPubMed
12.
go back to reference Howard RJ, Lieb S (1988) Soft-tissue infections caused by halophilic marine Vibrios. Arch Surg 123:245–249PubMed Howard RJ, Lieb S (1988) Soft-tissue infections caused by halophilic marine Vibrios. Arch Surg 123:245–249PubMed
13.
go back to reference Penman AD, Lanier DC Jr, Avara WT III et al (1995) Vibrio vulnificus wound infections from the Mississippi Gulf coastal waters: June to August 1993. South Med J 88:531–533PubMed Penman AD, Lanier DC Jr, Avara WT III et al (1995) Vibrio vulnificus wound infections from the Mississippi Gulf coastal waters: June to August 1993. South Med J 88:531–533PubMed
14.
go back to reference Halow KD, Harner RC, Fontenelle LJ (1996) Primary skin infections secondary to Vibrio vulnificus: the role of operative intervention. J Am Coll Surg 183:329–334PubMed Halow KD, Harner RC, Fontenelle LJ (1996) Primary skin infections secondary to Vibrio vulnificus: the role of operative intervention. J Am Coll Surg 183:329–334PubMed
15.
go back to reference Tsai YH, Hsu RW, Huang TJ et al (2007) Necrotizing soft-tissue infections and sepsis caused by Vibrio vulnificus compared with those caused by Aeromonas species. J Bone Joint Surg Am 89:631–636CrossRefPubMed Tsai YH, Hsu RW, Huang TJ et al (2007) Necrotizing soft-tissue infections and sepsis caused by Vibrio vulnificus compared with those caused by Aeromonas species. J Bone Joint Surg Am 89:631–636CrossRefPubMed
16.
go back to reference Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med 29:530–538PubMed Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med 29:530–538PubMed
17.
go back to reference Fagon JY, Chastre J, Novara A et al (1993) Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: the ODIN model. Intensive Care Med 19:137–144CrossRefPubMed Fagon JY, Chastre J, Novara A et al (1993) Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: the ODIN model. Intensive Care Med 19:137–144CrossRefPubMed
18.
go back to reference Abbott SL, Janda JM, Johnson JA (2007) Vibrio and related organisms. In: Murray PR, Baron EJ, Jorgensen JH et al (eds) Manual of clinical microbiology, vol I, 9th edn. ASM Press, Washington, pp 723–733 Abbott SL, Janda JM, Johnson JA (2007) Vibrio and related organisms. In: Murray PR, Baron EJ, Jorgensen JH et al (eds) Manual of clinical microbiology, vol I, 9th edn. ASM Press, Washington, pp 723–733
19.
20.
go back to reference Park SD, Shon HS, Joh NJ (1991) Vibrio vulnificus septicemia in Korea: clinical and epidemiologic findings in seventy patients. J Am Acad Dermatol 24:397–403CrossRefPubMed Park SD, Shon HS, Joh NJ (1991) Vibrio vulnificus septicemia in Korea: clinical and epidemiologic findings in seventy patients. J Am Acad Dermatol 24:397–403CrossRefPubMed
21.
go back to reference Schultz MJ, Olszyna DP, de Jonge E et al (2000) Reduced ex vivo chemokine production by polymorphonuclear cells after in vivo exposure of normal humans to endotoxin. J Infect Dis 182:1264–1267CrossRefPubMed Schultz MJ, Olszyna DP, de Jonge E et al (2000) Reduced ex vivo chemokine production by polymorphonuclear cells after in vivo exposure of normal humans to endotoxin. J Infect Dis 182:1264–1267CrossRefPubMed
23.
go back to reference Hor LI, Chang TT, Wang ST (1999) Survival of Vibrio vulnificus in whole blood from patients with chronic liver diseases: association with phagocytosis by neutrophils and serum ferritin levels. J Infect Dis 179:275–278CrossRefPubMed Hor LI, Chang TT, Wang ST (1999) Survival of Vibrio vulnificus in whole blood from patients with chronic liver diseases: association with phagocytosis by neutrophils and serum ferritin levels. J Infect Dis 179:275–278CrossRefPubMed
24.
go back to reference Shin SH, Shin DH, Ryu PY et al (2002) Proinflammatory cytokine profile in Vibrio vulnificus septicemic patients’ sera. FEMS Immunol Med Microbiol 33:133–138CrossRefPubMed Shin SH, Shin DH, Ryu PY et al (2002) Proinflammatory cytokine profile in Vibrio vulnificus septicemic patients’ sera. FEMS Immunol Med Microbiol 33:133–138CrossRefPubMed
25.
go back to reference Powell JL, Strauss KA, Wiley C et al (2003) Inflammatory cytokine response to Vibrio vulnificus elicited by peripheral blood mononuclear cells from chronic alcohol users is associated with biomarkers of cellular oxidative stress. Infect Immun 71:4212–4216CrossRefPubMed Powell JL, Strauss KA, Wiley C et al (2003) Inflammatory cytokine response to Vibrio vulnificus elicited by peripheral blood mononuclear cells from chronic alcohol users is associated with biomarkers of cellular oxidative stress. Infect Immun 71:4212–4216CrossRefPubMed
26.
go back to reference Kim HR, Rho HW, Jeong MH et al (1993) Hemolytic mechanism of cytolysin produced from Vibrio vulnificus. Life Sci 53:571–577CrossRefPubMed Kim HR, Rho HW, Jeong MH et al (1993) Hemolytic mechanism of cytolysin produced from Vibrio vulnificus. Life Sci 53:571–577CrossRefPubMed
27.
go back to reference Biosca EG, Amaro C (1996) Toxic and enzymatic activities of Vibrio vulnificus biotype 2 with respect to host specificity. Appl Environ Microbiol 62:2331–2337PubMed Biosca EG, Amaro C (1996) Toxic and enzymatic activities of Vibrio vulnificus biotype 2 with respect to host specificity. Appl Environ Microbiol 62:2331–2337PubMed
28.
go back to reference Chiang SR, Chuang YC (2003) Vibrio vulnificus infection: clinical manifestations, pathogenesis, and antimicrobial therapy. J Microbiol Immunol Infect 36:81–88PubMed Chiang SR, Chuang YC (2003) Vibrio vulnificus infection: clinical manifestations, pathogenesis, and antimicrobial therapy. J Microbiol Immunol Infect 36:81–88PubMed
29.
go back to reference de Araujo MRE, Aquino C, Scaramal E et al (2007) Vibrio vulnificus infection in São Paulo, Brazil: case report and literature review. Braz J Infect Dis 11:302–305PubMed de Araujo MRE, Aquino C, Scaramal E et al (2007) Vibrio vulnificus infection in São Paulo, Brazil: case report and literature review. Braz J Infect Dis 11:302–305PubMed
30.
go back to reference Bowdre JH, Hull JH, Cocchetto DM (1983) Antibiotic efficacy against Vibrio vulnificus in the mouse: superiority of tetracycline. J Pharmacol Exp Ther 225:595–598PubMed Bowdre JH, Hull JH, Cocchetto DM (1983) Antibiotic efficacy against Vibrio vulnificus in the mouse: superiority of tetracycline. J Pharmacol Exp Ther 225:595–598PubMed
31.
go back to reference Morris JG Jr, Tenney J (1985) Antibiotic therapy for Vibrio vulnificus infection. JAMA 253:1121–1122CrossRefPubMed Morris JG Jr, Tenney J (1985) Antibiotic therapy for Vibrio vulnificus infection. JAMA 253:1121–1122CrossRefPubMed
32.
go back to reference Hsueh PR, Chang JC, Chang SC et al (1995) In vitro antimicrobial susceptibility of Vibrio vulnificus isolated in Taiwan. Eur J Clin Microbiol Infect Dis 14:151–153CrossRefPubMed Hsueh PR, Chang JC, Chang SC et al (1995) In vitro antimicrobial susceptibility of Vibrio vulnificus isolated in Taiwan. Eur J Clin Microbiol Infect Dis 14:151–153CrossRefPubMed
33.
go back to reference Chuang YC, Liu JW, Ko WC et al (1997) In vitro synergism between cefotaxime and minocycline against Vibrio vulnificus. Antimicrob Agents Chemother 41:2214–2217PubMed Chuang YC, Liu JW, Ko WC et al (1997) In vitro synergism between cefotaxime and minocycline against Vibrio vulnificus. Antimicrob Agents Chemother 41:2214–2217PubMed
34.
go back to reference Tang HJ, Chang MC, Ko WC et al (2002) In vitro and in vivo activities of newer fluoroquinolones against Vibrio vulnificus. Antimicrob Agents Chemother 46:3580–3584CrossRefPubMed Tang HJ, Chang MC, Ko WC et al (2002) In vitro and in vivo activities of newer fluoroquinolones against Vibrio vulnificus. Antimicrob Agents Chemother 46:3580–3584CrossRefPubMed
35.
go back to reference Chuang YC, Ko WC, Wang ST et al (1998) Minocycline and cefotaxime in the treatment of experimental murine Vibrio vulnificus infection. Antimicrob Agents Chemother 42:1319–1322PubMed Chuang YC, Ko WC, Wang ST et al (1998) Minocycline and cefotaxime in the treatment of experimental murine Vibrio vulnificus infection. Antimicrob Agents Chemother 42:1319–1322PubMed
Metadata
Title
Predictors of Mortality in Skin and Soft-tissue Infections Caused by Vibrio vulnificus
Authors
Tsai-Nung Kuo Chou
Wai-Nang Chao
Cheng Yang
Ruey-Hong Wong
Kwo-Chang Ueng
Shiuan-Chih Chen
Publication date
01-07-2010
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 7/2010
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-010-0455-y

Other articles of this Issue 7/2010

World Journal of Surgery 7/2010 Go to the issue